Study S001270

Efficacy of Glucagon-like Peptide-1 Receptor Agonists According to Type 2 Diabetes Subtypes: an Italian Monocentric Retrospective Study

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06120556
Study type: OBSERVATIONAL
Status: COMPLETED
Enrollment: 130
Start: 2023-06-10
Primary completion: 2023-10-31
Lead sponsor: Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Conditions: Diabetes Mellitus, Type 2
Interventions: DRUG:GLP-1 receptor agonist
Results posted: FALSE
Individual participant data sharing: YES

Registered primary outcomes

Difference in HbA1c change from baseline (%) among SIDD, SIRD, MARD, MOD subtypes [Difference in HbA1c change from baseline will be evaluated at first follow-up visit (occurring 6-12 months from GLP-1RA initiation)]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.